Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

16 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

dbGaP phs000873 Exome sequencing of a family with thrombocytopenia and leukemia - Eligibility

- 26/3/24 - 6 formularios, 1 itemgroup, 3 items, 1 idioma
Itemgroup: IG.elig
Principal Investigator: Jorge Di Paola, MD, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, USA MeSH: Thrombocytopenia,Abnormal Erythrocytes,B-Cell Leukemia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000873 A family with a history of bleeding, variable thrombocytopenia, red cell macrocytosis and two cases of pre B-cell acute lymphoblastic leukemia was studied in a single visit. The family was assessed for bleeding history using a bleeding questionnaire. Additionally, complete blood counts were measured and whole blood was collected from five affected individuals and three unaffected individuals for DNA extraction and whole exome sequencing. The goal of this study is to determine the genetic cause of thrombocytopenia, red cell macrocytosis, and predisposition to leukemia in a family. It is hoped that the information obtained from this study will help researchers understand the genetic and molecular basis of platelet and red cell production, as well as leukemia predisposition.

pht004555.v1.p1

1 itemgroup 3 items

pht004556.v1.p1

1 itemgroup 5 items

pht004557.v1.p1

1 itemgroup 3 items

pht004558.v1.p1

1 itemgroup 5 items

pht004559.v1.p1

1 itemgroup 7 items

Advanced B-Cell Leukemia or Lymphoma (NCT00057811) - Reporting Period (ANHL01P1 NCT00057811)

- 20/9/21 - 1 formulario, 5 itemgroups, 70 items, 1 idioma
Itemgroups: Header, Patient characteristics, CNS involvement, Diagnostics and treatment, Lab values
ANHL01P1: Reporting Period Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma NCT00057811 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BA568824-31F6-08D7-E034-0003BA12F5E7

ANHL01P1: On Study NCT00057811

- 20/9/21 - 1 formulario, 4 itemgroups, 37 items, 1 idioma
Itemgroups: Header Module, Treatment administrative data, Diagnosis related information, CCRR MODULE
ANHL01P1: On Study NCT00057811 Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BA4755F9-8909-46E4-E034-0003BA12F5E7

NCT00057811 CHILDREN'S ONCOLOGY GROUP CYTOGENETICS REPORTING FORM [ANHL01P1]

- 20/9/21 - 1 formulario, 3 itemgroups, 17 items, 1 idioma
Itemgroups: Header, Miscellaneous Patient Information, CCRR MODULE
NCT00057811 CHILDREN'S ONCOLOGY GROUP CYTOGENETICS REPORTING FORM [ANHL01P1] Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BA472941-6B83-4501-E034-0003BA12F5E7

Drug/Agent Toxicity by Tissue/Organ NCT00057811 On-Study - COG: Diagnosis/Registry [ANHL01P1] - 2090320v3.0 - COG: Diagnosis/Registry [ANHL01P1]

- 17/9/21 - 1 formulario, 4 itemgroups, 30 items, 1 idioma
Itemgroups: Header, Demographics, Primary Diagnosis, CCRR MODULE
COG: Diagnosis/Registry [ANHL01P1] Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F47A18-28A9-232C-E034-0003BA12F5E7

Eligibility B Cell Leukemia NCT01626495

- 18/8/19 - 1 formulario, 2 itemgroups, 27 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01626495

Eligibility Refractory B-Lineage Leukemia NCT02370160

- 29/6/19 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02370160

Eligibility Leukemia NCT00528450

- 28/6/17 - 1 formulario, 1 itemgroup, 21 items, 1 idioma
Itemgroup: Criteria
Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00528450

Eligibility Leukemia NCT00002757

- 22/7/16 - 1 formulario, 1 itemgroup, 30 items, 1 idioma
Itemgroup: Criteria
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00002757

ANHL01P1: Death

- 3/7/15 - 1 formulario, 3 itemgroups, 13 items, 1 idioma
Itemgroups: Header, Death Assessment, CCRR MODULE
ANHL01P1: Death Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F3CF39-DAC9-242F-E034-0003BA12F5E7

ANHL01P1: Specimen Transmittal Form NCT00057811

- 29/6/15 - 1 formulario, 3 itemgroups, 24 items, 1 idioma
Itemgroups: Header, Specimen Information, CCRR MODULE
ANHL01P1: Specimen Transmittal Form NCT00057811 Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F4AC9E-7F52-271D-E034-0003BA12F5E7

ANHL01P1: Institutional Pathology Form [reload] NCT00057811

- 27/6/15 - 1 formulario, 5 itemgroups, 28 items, 1 idioma
Itemgroups: Header, Pathology evaluation, Results from fresh or frozen tissue, Results from paraffin embedded tissue, CCRR MODULE
ANHL01P1: Institutional Pathology Form [reload] NCT00057811 Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BA57175F-244D-0585-E034-0003BA12F5E7

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial